HS 6 (HS-6)

Subscribe to Selected New Research on HS 6

18 relevant articles (2 outcomes, 1 trials/studies) found for this Bio-Agent

Description: structure

Also Known As:

HS-6; 1,1'-oxydimethylene(2-formyl-3-carbamyl)pyridinium chloride; 1-(((3-(aminocarbonyl)pyridinio)methoxy)methyl)-2-((hydroxyimino)methyl)pyridinium dichloride

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Amines: 1233

Hydroxylamines: 11

Oximes: 229

Pralidoxime Compounds: 1

HS 6: 18

Related Diseases

1.	Poisoning 10/01/1976 - "The dependence of the blood level of the oxime HS-6 on the severity of organophosphate poisoning." 10/01/1978 - "The results indicate that HS-6 possesses ganglion-blocking properties at doses likely to be used in the protection against soman poisoning" 02/01/2005 - "HS-6, K033 and BI-6 as well as obidoxime were comparably effective antidotes against GF-agent intoxication and their therapeutic ratios were similar." 04/15/1978 - "The bisquaternary mono-oximes HS-6 and HI-6 may both be considered as potential therapeutic agents for soman intoxication" 04/15/1978 - "A comparison of the oximes HS-6 and HI-6 in the therapy of soman intoxication in rodents." Get all the results and reference details, order at left...
2.	Ganglion Cysts (Ganglion) 10/01/1978 - "The ganglion-blocking properties of the drug may be a factor in the beneficial effects of HS-6." 10/01/1978 - "The results indicate that HS-6 possesses ganglion-blocking properties at doses likely to be used in the protection against soman poisoning" 10/01/1978 - "Doses of HS-6 below those used to protect against soman in different animal species (10--30 mumol/kg) progressively blocked the ganglion-stimulating effects of nicotine and dimethylphenylpiperazinium but not the pressor effect following adrenaline, a pattern similar to that produced by hexamethonium but only 1/84 as potent" Get all the results and reference details, order at left...
3.	Septic Shock (Toxic Shock Syndrome) 04/01/2008 - "These septic shock dogs were resuscitated with hypertonic salt solutions (HS, 6 ml/kg, n = 6), 6% hydroxyethyl starch in combination with HS (HSS, 6 ml/kg, n=6), normal saline (NS, 100 ml/kg, n=6), and 6% hydroxyethyl starch solutions (HES, 33 ml/kg, n=6), respectively" Get all the results and reference details, order at left...
4.	Shock 03/01/2008 - "One hour after the induced shock, the dogs were given HS (6 ml/kg), RL of 3-fold volume of blood loss, HES of equivalent volume of blood loss, and HSH 8 ml/kg in the 4 groups, respectively" Get all the results and reference details, order at left...
5.	Sarcoma (Soft Tissue Sarcoma) 08/01/1952 - "Extirpation and transplantation of a sarcoma, HS-6, in the Syrian hamster." Get all the results and reference details, order at left...
10 Diseases and 18 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Soman
2.	HI 6 (H16)
3.	Atropine (Hyoscyamine)
4.	Pyridostigmine Bromide (Pyridostigmine)
5.	Clonazepam (Rivotril)
6.	Oximes
7.	Obidoxime Chloride (Obidoxime)
8.	BI 6
9.	Acetylcholinesterase
10.	cyclohexyl methylphosphonofluoridate (cyclosarin)
27 Drugs and Important Bio-Agents and 11 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Transplantation (Transplant Recipients)
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...

Research Interface Subscription

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Searches
2 clicks from Disease to Drug to Evidence
Trial references
All the Positive Outcomes
Drug and Therapy searches
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface Subscription

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>